Zestra®
Natural health product licensed in Canada
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80034229
- Status
- Inactive licence
- Licence date
- 30 July 2012
- Revision date
- 17 August 2022
- Form
- Huile
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Vitamine E, Vitamine C, Neotame, Ferulic acid, Ammonium glycyrrhizate, Poudre de cacao, Terre à foulon, Saveur de framboise, Extrait de racine de Cnidium officinale, Lactone d'acide 4-hydroxy-3-penténoïque
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 3 pompes | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily improve sexual desire/arousal in women suffering from female sexual interest/arousal disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80034229
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging